Rios Luci C - Search Results

1

Model-Based Nanoengineered Pharmacokinetics of Iron-Doped Copper Oxide for Nanomedical Applications.

Naatz H, Manshian BB, Rios Luci C, Tsikourkitoudi V, Deligiannakis Y, Birkenstock J, Pokhrel S, Mädler L, Soenen SJ. Naatz H, et al. Among authors: rios luci c. Angew Chem Int Ed Engl. 2020 Jan 27;59(5):1828-1836. doi: 10.1002/anie.201912312. Epub 2020 Jan 9. Angew Chem Int Ed Engl. 2020. PMID: 31755189 Free PMC article.

2

Gold nanoparticle delivery to solid tumors: a multiparametric study on particle size and the tumor microenvironment.

Izci M, Maksoudian C, Gonçalves F, Aversa L, Salembier R, Sargsian A, Pérez Gilabert I, Chu T, Rios Luci C, Bolea-Fernandez E, Nittner D, Vanhaecke F, Manshian BB, Soenen SJ. Izci M, et al. Among authors: rios luci c. J Nanobiotechnology. 2022 Dec 9;20(1):518. doi: 10.1186/s12951-022-01727-9. J Nanobiotechnology. 2022. PMID: 36494816 Free PMC article.

3

Cu-doped TiO₂ nanoparticles improve local antitumor immune activation and optimize dendritic cell vaccine strategies.

Hesemans E, Saffarzadeh N, Maksoudian C, Izci M, Chu T, Rios Luci C, Wang Y, Naatz H, Thieme S, Richter C, Manshian BB, Pokhrel S, Mädler L, Soenen SJ. Hesemans E, et al. Among authors: rios luci c. J Nanobiotechnology. 2023 Mar 13;21(1):87. doi: 10.1186/s12951-023-01844-z. J Nanobiotechnology. 2023. PMID: 36915084 Free PMC article.

4

Inorganic Nanoparticles Change Cancer-Cell-Derived Extracellular Vesicle Secretion Levels and Cargo Composition, Resulting in Secondary Biological Effects.

Buttiens K, Maksoudian C, Perez Gilabert I, Rios Luci C, Manshian BB, Soenen SJ. Buttiens K, et al. Among authors: rios luci c. ACS Appl Mater Interfaces. 2024 Jan 10;16(1):66-83. doi: 10.1021/acsami.3c12680. Epub 2024 Jan 1. ACS Appl Mater Interfaces. 2024. PMID: 38163254

5

The Efficacy of Nanoparticle Delivery to Hypoxic Solid Tumors by ciRGD Co-Administration Depends on Neuropilin-1 and Neutrophil Levels.

Izci M, Maksoudian C, Gonçalves F, Pérez Gilabert I, Rios Luci C, Bolea-Fernandez E, Vanhaecke F, Manshian BB, Soenen SJ. Izci M, et al. Among authors: rios luci c. Adv Healthc Mater. 2023 Sep;12(24):e2300594. doi: 10.1002/adhm.202300594. Epub 2023 Jun 7. Adv Healthc Mater. 2023. PMID: 37247322

6

Adaptive resistance to trastuzumab impairs response to neratinib and lapatinib through deregulation of cell death mechanisms.

Ríos-Luci C, Díaz-Rodríguez E, Gandullo-Sánchez L, Díaz-Gil L, Ocaña A, Pandiella A. Ríos-Luci C, et al. Cancer Lett. 2020 Feb 1;470:161-169. doi: 10.1016/j.canlet.2019.11.026. Epub 2019 Nov 22. Cancer Lett. 2020. PMID: 31765734

7

CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.

Dinić J, Ríos-Luci C, Karpaviciene I, Cikotiene I, Fernandes MX, Pešić M, Padrón JM. Dinić J, et al. Among authors: rios luci c. Invest New Drugs. 2020 Jun;38(3):584-598. doi: 10.1007/s10637-019-00803-6. Epub 2019 Jun 8. Invest New Drugs. 2020. PMID: 31177401

8

TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells.

Díaz-Rodríguez E, Pérez-Peña J, Ríos-Luci C, Arribas J, Ocaña A, Pandiella A. Díaz-Rodríguez E, et al. Among authors: rios luci c. Cancer Lett. 2019 Jul 1;453:34-44. doi: 10.1016/j.canlet.2019.03.042. Epub 2019 Mar 27. Cancer Lett. 2019. PMID: 30928382

9

Resistance to the Antibody-Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity.

Ríos-Luci C, García-Alonso S, Díaz-Rodríguez E, Nadal-Serrano M, Arribas J, Ocaña A, Pandiella A. Ríos-Luci C, et al. Cancer Res. 2017 Sep 1;77(17):4639-4651. doi: 10.1158/0008-5472.CAN-16-3127. Epub 2017 Jul 7. Cancer Res. 2017. PMID: 28687619

10

DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells.

Podolski-Renić A, Banković J, Dinić J, Ríos-Luci C, Fernandes MX, Ortega N, Kovačević-Grujičić N, Martín VS, Padrón JM, Pešić M. Podolski-Renić A, et al. Among authors: rios luci c. Eur J Pharm Sci. 2017 Jul 15;105:159-168. doi: 10.1016/j.ejps.2017.05.011. Epub 2017 May 11. Eur J Pharm Sci. 2017. PMID: 28502672

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page